Development and Validation of RP-HPLC Method for the Determination of Febuxostat in Bulk and Pharmaceutical Dosage Form Darandale D. M.1,*, Erande K. B.1, Tambe S. R.2, Bhamber R. S.3 1Department of Quality Assurance Techniques, MGV's Pharmacy College, Panchvati, Nashik, Maharashtra, India. 422002 2Department of Pharmaceutical Chemistry, MGV's Pharmacy College, Panchvati, Nashik, Maharashtra, India. 422002 3Department of Pharmacognosy, SPH College of Pharmacy, Malegaon, Nashik, Maharashtra, India *Corresponding Author E-mail: d.darandale@gmail.com
Online published on 26 March, 2018. Abstract The objective of the present work was to develop a simple and accurate RP-HPLC method for the estimation of febuxostat in bulk and pharmaceutical dosage forms, using grace C18 (250mm x 4.6ID, Particle size: 5 micron) in isocratic mode, with mobile phase Methanol: Potassium Di-Hydrogen Phosphate10mM Buffer pH: 6.8 (70: 30). The flow rate was 0.8 ml/min and the detection was monitored by UV detector at 315nm. The retention time for febuxostat was found to be 7.08 min. The proposed method has permitted the quantification of febuxostat over linearity in the range of 10–50 μg/ml and its percentage recovery was found to be 99.72%. The intraday and inter day precision were found 0.13% and 0.35%, respectively. Top Keywords RP-HPLC, Validation, Febuxostat, Gout, Recovery. Top |